This is crowd sourcing in a small way, implemented by the FDA through an unusual approach. Always known as being overloaded and understaffed, the FDA has established the “Bad Ad Program” in which it has asked medical professionals to review and report back to the FDA via anonymous email address, any marketing material that is not complaint with fair balance or suggested for use through off-label marketing as established by the FDA. 

The FDA has been in the news a ton lately with tremendous scrutiny on an Ann Taylor blog nailing them for incentivize customers to write about a brand, they have issued severe warning letters to many pharma companies for improper marketing and now again with this HCP enabled review committee.  What’s next for the FDA – time will tell.  As partners to all of our pharma clients, we MUST ensure all of our media and creative efforts are fully compliant.

Read up here:  FDA Deputizes Doctors